CACaption Management, LLC
Institutional investor · Portfolio as of Q4 2022
Top Holdings1,231 positions
MICROSOFT CORP | 550,000 | $131.9M | 2.1% | — | — | — | Unchanged — |
HORIZON THERAPEUTICS PLC | 1.1M | $127.6M | 2.0% | — | — | — | Increased — |
CATERPILLAR INC | 360,000 | $86.2M | 1.3% | — | — | — | New — |
PALO ALTO NETWORKS INC | 602,100 | $84M | 1.3% | — | — | — | Decreased — |
KRANESHARES TRUST | 2.7M | $82.7M | 1.3% | — | — | — | Increased — |
NORTHROP GRUMMAN CORP | 147,500 | $80.5M | 1.3% | — | — | — | New — |
DEVON ENERGY CORP NEW | 1.3M | $80.3M | 1.3% | — | — | — | Decreased — |
SELECT SECTOR SPDR TR | 684,700 | $67.2M | 1.0% | — | — | — | New — |
SPDR SERIES TRUST | 805,000 | $66.8M | 1.0% | — | — | — | Decreased — |
ACTIVISION BLIZZARD INC | 871,500 | $66.7M | 1.0% | — | — | — | Increased — |
CAESARS ENTERTAINMENT INC NE | 1.5M | $64.1M | 1.0% | — | — | — | Increased — |
PROMETHEUS BIOSCIENCES INC | 552,300 | $60.8M | 0.9% | — | — | — | Increased — |
BIOGEN INC | 206,800 | $57.3M | 0.9% | — | — | — | Decreased — |
EXXON MOBIL CORP | 494,300 | $54.5M | 0.9% | — | — | — | Decreased — |
SUNRUN INC | 2.1M | $49.3M | 0.8% | — | — | — | Increased — |
BIOGEN INC | 174,300 | $48.3M | 0.8% | — | — | — | Decreased — |
CHEVRON CORPORATION | 256,500 | $46M | 0.7% | — | — | — | Decreased — |
OCCIDENTAL PETE CORP | 728,000 | $45.9M | 0.7% | — | — | — | Decreased — |
CHARTER COMMUNICATIONS INC | 134,200 | $45.5M | 0.7% | — | — | — | Increased — |
CHARTER COMMUNICATIONS INC | 127,700 | $43.3M | 0.7% | — | — | — | Increased — |
Caption Management, LLC manages $6.4B across 1231 positions as of Q4 2022. Top holdings: MSFT puts (2.1%), HZNP puts (2.0%), CAT puts (1.3%). Fund DNA: Momentum Trader. HoldingsIntel Score: 1/5.0.
Active quarter - 152 new positions, 244 exits, 119 increased. No standout high-conviction moves this quarter. Portfolio: $6.4B across 1231 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR